IGF2 and hepatoblastoma: Zhen [32] found that in hepatoblastoma, circHMGCS1 and insulin-like growth factor 2 (IGF2) were significantly upregulated and negatively correlated with the prognosis of patients, which is expected to be the biomarkers for the diagnosis and prognosis.